Sweet itch vaccine ‘will make a huge difference’

IPCIMMGLPICT000005375297.jpg
INJECTION FLU INJECT
(Image credit: credits-unknown)

A company is working on a vaccination against sweet itch, which it hopes will be on the market by 2020-21.

Benchmark Holdings, an “innovation company” specialising in agriculture and animal health, is working with Swiss equine biotech firm Evax AG on developing the vaccine.

Eleanor Jones
News editor

Eleanor is an experienced journalist who spent over eight years working for local and national newspapers before joining H&H as news editor in March 2016. Passionate about equine welfare and exposing the truth, Eleanor has reported on all aspects of the industry, from Brexit to anti-bullying campaigns, and from dressage rules to mules. Her sport of choice is showjumping, in which she competes her own horses, and she also enjoys reporting at local jumping shows through to international championships.